订阅小程序
旧版功能

1MO the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection (PH FDC SC) in Chinese Patients (pts) with HER2-positive Early Breast Cancer (EBC): Primary Analysis of the Phase III, Randomised FDChina Study

Z. Shao, T. Huang,Z. Fan,Y. Wang,X. Yan,H. Yang,S. Wang,D. Pang, H. Li,H. Wang,C. Geng,L. Huang, A. Siddiqui, B. Wang, B. Xie, G. Sun,E. Restuccia

Annals of Oncology（2022）

引用 0|浏览3
关键词
Trastuzumab,Breast Cancer,Fc? Receptors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要